175 related articles for article (PubMed ID: 11069808)
1. Recombinant tissue factor pathway inhibitor reduces lipopolysaccharide-induced pulmonary vascular injury by inhibiting leukocyte activation.
Enkhbaatar P; Okajima K; Murakami K; Uchiba M; Okabe H; Okabe K; Yamaguchi Y
Am J Respir Crit Care Med; 2000 Nov; 162(5):1752-9. PubMed ID: 11069808
[TBL] [Abstract][Full Text] [Related]
2. Recombinant tissue factor pathway inhibitor prevents lipopolysaccharide-induced systemic hypotension in rats by inhibiting excessive production of nitric oxide.
Enkhbaatar P; Okajima K; Uchiba M; Isobe H; Okabe H
Thromb Haemost; 2001 Dec; 86(6):1573-7. PubMed ID: 11776329
[TBL] [Abstract][Full Text] [Related]
3. Dalteparin, a low molecular weight heparin, attenuates inflammatory responses and reduces ischemia-reperfusion-induced liver injury in rats.
Harada N; Okajima K; Uchiba M
Crit Care Med; 2006 Jul; 34(7):1883-91. PubMed ID: 16641616
[TBL] [Abstract][Full Text] [Related]
4. Endotoxin-induced pulmonary vascular injury is mainly mediated by activated neutrophils in rats.
Uchiba M; Okajima K; Murakami K; Okabe H; Takatsuki K
Thromb Res; 1995 Apr; 78(2):117-25. PubMed ID: 7482429
[TBL] [Abstract][Full Text] [Related]
5. The prevention of lipopolysaccharide-induced pulmonary vascular injury by pretreatment with cepharanthine in rats.
Murakami K; Okajima K; Uchiba M
Am J Respir Crit Care Med; 2000 Jan; 161(1):57-63. PubMed ID: 10619798
[TBL] [Abstract][Full Text] [Related]
6. Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats.
Murakami K; Okajima K; Uchiba M; Johno M; Nakagaki T; Okabe H; Takatsuki K
Blood; 1996 Jan; 87(2):642-7. PubMed ID: 8555486
[TBL] [Abstract][Full Text] [Related]
7. Effects of plasma kallikrein specific inhibitor and active-site blocked factor VIIa on the pulmonary vascular injury induced by endotoxin in rats.
Uchiba M; Okajima K; Murakami K; Okabe H; Okamoto S; Okada Y
Thromb Haemost; 1997 Oct; 78(4):1209-14. PubMed ID: 9364986
[TBL] [Abstract][Full Text] [Related]
8. Effect of nafamostat mesilate on pulmonary vascular injury induced by lipopolysaccharide in rats.
Uchiba M; Okajima K; Murakami K; Okabe H; Takatsuki K
Am J Respir Crit Care Med; 1997 Feb; 155(2):711-8. PubMed ID: 9032217
[TBL] [Abstract][Full Text] [Related]
9. Adenosine and selective A(2A) receptor agonists reduce ischemia/reperfusion injury of rat liver mainly by inhibiting leukocyte activation.
Harada N; Okajima K; Murakami K; Usune S; Sato C; Ohshima K; Katsuragi T
J Pharmacol Exp Ther; 2000 Sep; 294(3):1034-42. PubMed ID: 10945856
[TBL] [Abstract][Full Text] [Related]
10. Effects of recombinant human tissue factor pathway inhibitor on thrombus formation and its in vivo distribution in a rat DIC model.
Elsayed YA; Nakagawa K; Kamikubo YI; Enjyoji KI; Kato H; Sueishi K
Am J Clin Pathol; 1996 Nov; 106(5):574-83. PubMed ID: 8929465
[TBL] [Abstract][Full Text] [Related]
11. Thrombin and factor Xa enhance neutrophil chemoattractant production after ischemia/reperfusion in the rat liver.
Yamaguchi Y; Okabe K; Liang J; Ohshiro H; Ishihara K; Uchino S; Zhang JL; Hidaka H; Yamada S; Ogawa M
J Surg Res; 2000 Jul; 92(1):96-102. PubMed ID: 10864488
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological profiling of recombinant tissue factor pathway inhibitor.
Jeske W; Hoppensteadt D; Callas D; Koza MJ; Fareed J
Semin Thromb Hemost; 1996; 22(2):213-9. PubMed ID: 8807720
[TBL] [Abstract][Full Text] [Related]
13. Antithrombin III (AT III) prevents LPS-induced pulmonary vascular injury: novel biological activity of AT III.
Uchiba M; Okajima K
Semin Thromb Hemost; 1997; 23(6):583-90. PubMed ID: 9469634
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human soluble thrombomodulin reduces endotoxin-induced pulmonary vascular injury via protein C activation in rats.
Uchiba M; Okajima K; Murakami K; Nawa K; Okabe H; Takatsuki K
Thromb Haemost; 1995 Nov; 74(5):1265-70. PubMed ID: 8607107
[TBL] [Abstract][Full Text] [Related]
15. Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production.
Murakami K; Okajima K; Uchiba M; Johno M; Nakagaki T; Okabe H; Takatsuki K
Am J Physiol; 1997 Feb; 272(2 Pt 1):L197-202. PubMed ID: 9124369
[TBL] [Abstract][Full Text] [Related]
16. Natural anticoagulants limit lipopolysaccharide-induced pulmonary coagulation but not inflammation.
Choi G; Vlaar AP; Schouten M; Van't Veer C; van der Poll T; Levi M; Schultz MJ
Eur Respir J; 2007 Sep; 30(3):423-8. PubMed ID: 17537762
[TBL] [Abstract][Full Text] [Related]
17. N-acetyl cysteine attenuates acute lung injury in the rat.
Davreux CJ; Soric I; Nathens AB; Watson RW; McGilvray ID; Suntres ZE; Shek PN; Rotstein OD
Shock; 1997 Dec; 8(6):432-8. PubMed ID: 9421857
[TBL] [Abstract][Full Text] [Related]
18. Recombinant tissue factor pathway inhibitor enhances the binding of factor Xa to human monocytes.
Li A; Chang AC; Peer GT; Wun TC; Taylor FB
Thromb Haemost; 2001 May; 85(5):830-6. PubMed ID: 11372676
[TBL] [Abstract][Full Text] [Related]
19. [Adenosine reduces ischemia/reperfusion-induced liver injury by inhibiting leukocyte activation].
Harada N; Okajima K; Katsuragi T
Nihon Yakurigaku Zasshi; 1999 Oct; 114 Suppl 1():159P-167P. PubMed ID: 10629874
[TBL] [Abstract][Full Text] [Related]
20. Gabexate mesilate, a synthetic protease inhibitor, attenuates endotoxin-induced pulmonary vascular injury by inhibiting tumor necrosis factor production by monocytes.
Murakami K; Okajima K; Uchiba M; Okabe H; Takatsuki K
Crit Care Med; 1996 Jun; 24(6):1047-53. PubMed ID: 8681572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
